Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit
Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit
This is a Phase 4, single-center, open-label, interventional study, wherein all enrolled
 subjects will be tested for Thyroid Stimulating Hormone (TSH) by using the quantitative and
 the qualitative Point-of-Care (POC) TSH test kits and the third generation TSH test kit at
 the same time.
Inclusion Criteria:

 -  Suspected hypothyroidism subject

 -  Willing to comply with the trial protocol

 -  Signed informed consent document

 Exclusion Criteria:

 -  Menstrual period, bleeding hemorrhoids, hematuria

 -  Drinking or taking aspirin within 48 hours

 -  Subjects with partially or completely restricted consciousness and behavioral ability,
 who do not have independent decision-making ability.

 -  Subjects who are unwilling or unable to complete the trial

 -  Subjects who do not sign informed consent form